PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
ACAT2 145 Target Disease Cholesterol 182,390 122 0.02 -0.40 0.84 0.65
ACAT2 145 Target Target Peroxisome Proliferator-Activated Receptor Delta 355 1 0.00 -1.00 0.01 0.70
ACAT2 145 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.01 0.53
ACAT2 145 Target Target Sphingomyelinase 3,060 1 0.00 -1.00 0.01 0.63
ACAT2 145 Target Disease Dyslipidemia 15,225 2 0.00 -0.99 0.01 0.60
ACAT2 145 Target Disease Pain 409,851 1 0.00 -1.00 0.01 0.51
ACAT2 145 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
ACAT2 145 Target Disease Down Syndrome 10,290 1 0.00 -1.00 0.01 0.59
ACAT2 145 Target Disease Hyperlipidemia 15,317 5 0.00 -0.98 0.03 0.63
ACAT2 145 Target Disease Lung Cancer 91,416 2 0.00 -0.99 0.01 0.56
ACAT2 145 Target Disease Inflammation 252,734 1 0.00 -1.00 0.01 0.52
ACAT2 145 Target Disease Liver Disease 49,817 2 0.00 -0.99 0.01 0.57
ACAT2 145 Target Disease Heart Disease 118,291 5 0.00 -0.98 0.03 0.57
ACAT2 145 Target Disease Infertility 35,448 1 0.00 -1.00 0.01 0.56
ACAT2 145 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.01 0.59
ACAD8 11 Target Disease Prostate Cancer 71,064 1 0.00 -0.95 0.09 0.59
ACAD8 11 Target Disease Dehydration 21,928 1 0.00 -0.95 0.09 0.62
ACAD8 11 Target Disease Anemia 81,663 1 0.00 -0.95 0.09 0.59
ACAD8 11 Target Target APOE 12,771 1 0.00 -0.95 0.09 0.63
ACAD8 11 Target Disease Cholesterol 182,390 1 0.00 -0.95 0.09 0.57
AACT 109 Target Disease Hepatitis B 57,815 1 0.00 -1.00 0.01 0.56
AACT 109 Target Disease Lung Carcinoma 13,423 1 0.00 -1.00 0.01 0.59
AACT 109 Target Target AFP 9,751 1 0.00 -1.00 0.01 0.60
AACT 109 Target Disease Shock 134,031 1 0.00 -1.00 0.01 0.54
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
AACT 109 Target Target APOE 12,771 11 0.01 -0.95 0.10 0.66
AACT 109 Target Disease Hypocalcemia 6,174 1 0.00 -1.00 0.01 0.61
AACT 109 Target Target Collagen 138,882 4 0.00 -0.98 0.04 0.57
AACT 109 Target Disease Hepatitis 163,842 3 0.00 -0.99 0.03 0.56
AACT 109 Target Disease Menopause 19,680 1 0.00 -1.00 0.01 0.58
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
AACT 109 Target Target Toll-Like Receptor 2 2,174 1 0.00 -1.00 0.01 0.64
AACT 109 Target Disease Dementia 66,782 3 0.00 -0.99 0.03 0.58
AACT 109 Target Disease Sepsis 64,798 1 0.00 -1.00 0.01 0.55
AACT 109 Target Disease Pain 409,851 2 0.00 -0.99 0.02 0.53
AACT 109 Target Disease Leukemia 162,805 2 0.00 -0.99 0.02 0.55
AACT 109 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
AACT 109 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
AACT 109 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.55
AACT 109 Target Disease Inflammation 252,734 2 0.00 -0.99 0.02 0.54
AACT 109 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.01 0.56
AACT 109 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.01 0.54
AACT 109 Target Target BCHE 1,167 2 0.01 -0.99 0.02 0.68
AACT 109 Target Disease Anxiety Disorder 8,985 1 0.00 -1.00 0.01 0.60
A1M 59 Target Disease Infection 766,637 3 0.00 -0.97 0.05 0.54
A1M 59 Target Disease Kidney Diseases 4,651 1 0.00 -0.99 0.02 0.63
A1M 59 Target Target B2M 677 9 0.05 -0.91 0.15 0.77
A1M 59 Target Disease Glomerulonephritis 23,459 1 0.00 -0.99 0.02 0.59
A1M 59 Target Disease Shock 134,031 1 0.00 -0.99 0.02 0.55
A1M 59 Target Disease Renal Failure 73,993 1 0.00 -0.99 0.02 0.56